Presidency of the
Council of Ministers
Arwan Pharmaceutical Industries, are one of the most advanced biotech manufacturing facilities in the MENA region and Africa.
They develop and manufacture critical care products, focusing on new generation anti-infectives, hematinics, anesthetics and analgesics, gastrointestinals, oncology, antiasthmatics, cardiovasculars, osteoporosis and wound management modalities.
Investment Size: USD 35.4 million
Jobs to be Created: 90
Type of Investment: Foreign Affiliate
Nationality of Investor: Lebanese – Emirati
Approval Date: 2011
Operation Date: 2013
Type of Incentive Scheme from IDAL: Package Deal Contract (PDC)
For more information, please download the Project Fiche.